Concourse Financial Group Securities, Inc. Rhythm Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
66.8MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$676 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$562 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$558 Million7.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$501 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$489 Million0.25% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.59B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...